APA Alıntı

Fang, P., Zhang, L., Zhang, X., Yu, J., Sun, J., Jiang, Q., . . . Cao, H. (2019). Apatinib Mesylate in the treatment of advanced progressed lung adenocarcinoma patients with EGFR-TKI resistance —A Multicenter Randomized Trial. Sci Rep.

Chicago Stili Alıntı

Fang, Ping, Liqin Zhang, Xianru Zhang, Jiawen Yu, Jun Sun, Qi-an Jiang, Mingbao Zha, Anastasia P. Nesterova, ve Hongbao Cao. "Apatinib Mesylate in the Treatment of Advanced Progressed Lung Adenocarcinoma Patients With EGFR-TKI Resistance —A Multicenter Randomized Trial." Sci Rep 2019.

MLA Alıntı

Fang, Ping, et al. "Apatinib Mesylate in the Treatment of Advanced Progressed Lung Adenocarcinoma Patients With EGFR-TKI Resistance —A Multicenter Randomized Trial." Sci Rep 2019.